Speaking at the 7th TPD & Induced Proximity Summit Europe

8:00 am - Wednesday 17th March 2027

Speakers:

Christian Steinebach
Professor - Pharmaceutical & Medicinal Chemistry
University of Greifswald
Benedict Cross
Founder & Chief Executive Officer
Stick Therapeutics
Monica Rodrigo
Director - PROTAC Safety Sciences
AstraZeneca
Andrew Potterton
Chief Technology Officer & Co-Founder C-Suite; Engineering & Technical
Ternary Therapeutics
Paola Martinelli
Associate Director - Scientific
Boehringer Ingelheim
Yvonne Mcgrath
Chief Scientific Officer
Enodia Therapeutics
Natalie Scholes
Group Leader
The Netherlands Cancer Institute
Magnus Walter
Chief Technology Officer
Monte Rosa Therapeutics
Maureen Spit
Vice President Research
Laigo Bio
Zuzanna Kozicka
Assistant Professor
Swiss Federal Institute of Technology in Lausanne
Giovanni Spagnolli
Co-Founder & Chief Technology Officer
Sibylla Biotech srl
James Lynch
Director - Oncology
Amphista Therapeutics
Robert Johnson
Chief Executive Officer
Kesmalea Therapeutics
Stephen Myatt
Chief Executive Officer
Macomics
Daniele Simoneschi
Chief Executive Officer & Co-Founder
Molecular Glue Labs
Eran Seger
Chief Executive Officer & Co-founder
Protai
Christopher Tame
Founder & Chief Executive Officer
Ternary Therapeutics
Sophie Regan
Associate Director, PROTAC Safety Science
AstraZeneca
Tim Barrett
Director - Medicinal Chemistry & Modality Platform Technologies
GlaxoSmithKline
Emanuela Cuomo
Executive Director, Global Head of Discovery Pharmacology
EMD Serono
Marcus Rosenblatt
Principal Scientist - Preclinical Modeling Simulation, NCE DMPK
Merck KGaA
Jemima Thomas
Senior Research Associate
The Francis Crick Institute
Ali Tavassoli
Professor - Chemical Biology
Southampton University
Luke Rajah
Partner
BGF
Jon Travers
Director, Oncology BD&L
MSD
Willem Broekaert
Managing Partner
V-Bio Ventures